Sort
11,323 grants matching “glioblastoma”
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMAS
$655,952Pavithra Viswanath · University Of California, San Francisco · R01 · FY2023 · CA
Using experimentally-guided multi-scale modeling to determining the mechanism of FLASH tissue sparing
$655,900Jan Patrick Oscar Schuemann · Massachusetts General Hospital · R01 · FY2023 · CA
Novel therapeutic approach in treatment of glioblastoma using sustained delivery of Connxin43 carboxy-terminal peptide encapsulated in biodegradable nanoparticles in combination with temozolomide
$655,532Christina Grek · Xequel Bio, Inc. · R44 · FY2019 · CA
Pre-clinical Development of Radiation Sensitizers for Patients with Glioblastoma
$655,320Kevin Camphausen · Division Of Clinical Sciences - Nci · ZIA · FY2024 · CA
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma
$654,737Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R35 · FY2023 · NS
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma
$654,737Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R35 · FY2025 · NS
Image-based models of tumor-immune dynamics in glioblastoma
$654,652Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2023 · CA
Novel therapeutics for the targeted eradication of DDR-defective tumors
$654,163Seth B. Herzon · Yale University · R01 · FY2025 · CA
Novel therapeutics for the targeted eradication of DDR-defective tumors
$654,163Seth B. Herzon · Yale University · R01 · FY2023 · CA
Immune dysregulation mechanisms of persistent post-COVID19 olfactory dysfunction
$653,547Lora Bankova · Brigham And Women'S Hospital · R01 · FY2024 · DC
GENE EXPRESSION BASED CLASSIFICATION OF GLIAL TUMORS
$653,327University Of California Los Angeles · U01 · FY2001 · CA
Defining the role of cytomegalovirus in glioblastoma therapies
$653,127Sean Edward Lawler · Brown University · R01 · FY2025 · CA
Bioactivity of CAR T cells secreting T cell engager-anitbodies in humans with glioblastoma
$652,851Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2025 · CA
Lentiviral Vectors to Model Human Gliomas in Mice
$652,800Inder Mohan Verma · Salk Institute For Biological Studies · R01 · FY2014 · HL
MAPK-driven kinetochore stress in cancer
$652,799Patrick Paddison · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Antibody Drug Conjugate Designs to Enhance the Therapeutic Window for Brain Tumors
$652,751Jann N Sarkaria · Mayo Clinic Rochester · R01 · FY2025 · NS
Bioactivity of CAR T cells secreting T cell engager-anitbodies in humans with glioblastoma
$652,725Marcela Valderrama Maus · Massachusetts General Hospital · R01 · FY2024 · CA
Development and Dissemination of Clinical CEST MRI Acquisition and Analysis Methods for Cancer Imaging Applications
$652,625Mark David Pagel · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
Single Cell Analysis of the Infiltrative Margins of Glioblastoma and Post Treatment Recurrence
$652,348Jeffrey N Bruce · Columbia University Health Sciences · R01 · FY2023 · NS
Rb TS inhibition dedifferentiates astrocytes leading to Astrocytoma initiation
$652,207Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The study of underlying mechanism of EGFR-Ras signaling in glioblastoma
$652,207Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
The impact of interstitial fluid flow on CAR T cell trafficking, distribution, and efficacy
$652,200Jennifer M Munson · Virginia Polytechnic Inst And St Univ · R01 · FY2025 · NS
Exploiting cell fate transition to overcome radiation resistance in glioblastoma
$652,198Erik Sulman · New York University School Of Medicine · R01 · FY2024 · CA
MR-Guided Focused Ultrasound Combined with Immunotherapy to Treat Malignant Brain Tumors
$652,022Max Wintermark · Stanford University · R01 · FY2017 · CA
Quantifying Multiscale Competitive Landscapes of Clonal Diversity in Glioblastoma
$651,460Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2019 · CA